Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Cdc42EP3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA557102
Description
Immunogen sequence: SLPTIGGSQA LMLPLLSPVT FNSKQESFGP AKLPRLSCEP VMEEKAQEKS SLLENGTVHQ GDTSW Highest antigen sequence identity to the following orthologs: Mouse - 91%, Rat - 92%.
CDC42, a small Rho GTPase, regulates the formation of F-actin-containing structures through its interaction with the downstream effector proteins. The protein encoded by this gene is a member of the Borg family of CDC42 effector proteins. Borg family proteins contain a CRIB (Cdc42/Rac interactive-binding) domain. They bind to, and negatively regulate the function of, CDC42. This protein can interact with CDC42, as well as with the ras homolog gene family, member Q (ARHQ/TC10). Expression of this protein in fibroblasts has been shown to induce pseudopodia formation.
Specifications
Cdc42EP3 | |
Polyclonal | |
Unconjugated | |
CDC42EP3 | |
3200001F04Rik; AA986861; Binder of Rho GTPases 2; BORG2; CDC42 effector protein (Rho GTPase binding) 3; CDC42 effector protein 3; Cdc42ep3; CEP3; CRIB-containing BORG2 protein; MSE55-related Cdc42-binding protein; MSE55-related protein; UB1 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
10602 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9UKI2 | |
CDC42EP3 | |
Recombinant protein corresponding to Human Cdc42EP3. Recombinant protein control fragment (Product #RP-96179). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction